Suppr超能文献

设计锌指蛋白与 HIV-1 整合酶识别序列在 2-LTR 环交界处相互作用。

Designed zinc finger protein interacting with the HIV-1 integrase recognition sequence at 2-LTR-circle junctions.

机构信息

Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.

出版信息

Protein Sci. 2009 Nov;18(11):2219-30. doi: 10.1002/pro.233.

Abstract

Integration of HIV-1 cDNA into the host genome is a crucial step for viral propagation. Two nucleotides, cytosine and adenine (CA), conserved at the 3' end of the viral cDNA genome, are cleaved by the viral integrase (IN) enzyme. As IN plays a crucial role in the early stages of the HIV-1 life cycle, substrate blockage of IN is an attractive strategy for therapeutic interference. In this study, we used the 2-LTR-circle junctions of HIV-1 DNA as a model to design zinc finger protein (ZFP) targeting at the end terminal portion of HIV-1 LTR. A six-contiguous ZFP, namely 2LTRZFP was designed using zinc finger tools. The designed motif was expressed and purified from E. coli to determine its binding properties. Surface plasmon resonance (SPR) was used to determine the binding affinity of 2LTRZFP to its target DNA. The level of dissociation constant (K(d)) was 12.0 nM. The competitive SPR confirmed that 2LTRZFP specifically interacted with its target DNA. The qualitative binding activity was subsequently determined by EMSA and demonstrated the aforementioned correlation. In addition, molecular modeling and binding energy analyses were carried out to provide structural insight into the binding of 2LTRZFP to the specific and nonspecific DNA target. It is suggested that hydrogen-bonding interactions play a key role in the DNA recognition mechanisms of the designed ZFP. Our study suggested an alternative HIV therapeutic strategy using ZFP interference of the HIV integration process.

摘要

HIV-1 cDNA 整合到宿主基因组中是病毒繁殖的关键步骤。病毒整合酶 (IN) 酶切割病毒 cDNA 基因组 3' 端保守的两个核苷酸,胞嘧啶和腺嘌呤 (CA)。由于 IN 在 HIV-1 生命周期的早期阶段发挥着关键作用,因此抑制 IN 的底物结合是一种有吸引力的治疗干预策略。在这项研究中,我们使用 HIV-1 DNA 的 2-LTR 环接头作为模型,设计针对 HIV-1 LTR 末端部分的锌指蛋白 (ZFP)。使用锌指工具设计了一个六个连续的 ZFP,即 2LTRZFP。设计的基序从大肠杆菌中表达和纯化,以确定其结合特性。表面等离子体共振 (SPR) 用于确定 2LTRZFP 与其靶 DNA 的结合亲和力。离解常数 (K(d)) 的水平为 12.0 nM。竞争性 SPR 证实 2LTRZFP 特异性与其靶 DNA 相互作用。随后通过 EMSA 确定了定性结合活性,并证明了上述相关性。此外,进行了分子建模和结合能分析,以提供结构上对 2LTRZFP 与特定和非特定 DNA 靶标结合的理解。研究表明,氢键相互作用在设计的 ZFP 的 DNA 识别机制中起着关键作用。我们的研究提出了一种使用 ZFP 干扰 HIV 整合过程的替代 HIV 治疗策略。

相似文献

引用本文的文献

本文引用的文献

6
Raltegravir: an integrase inhibitor for HIV-1.雷特格韦:一种用于治疗HIV-1的整合酶抑制剂。
Expert Opin Investig Drugs. 2008 Mar;17(3):413-22. doi: 10.1517/13543784.17.3.413.
7

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验